Tanya Parish

Also affiliated with University of Washington

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 22 papers. Top paper: “The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis”.

The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis

Proceedings of the National Academy of Sciences(2007)10.1073/pnas.0704132104

N/A

0.750DataRank · unranked

147 citations

Adrian Suarez Covarrubias, Helen M. O'Hare, Paul Carroll, Nathalie Eynard, T. Alwyn Jones +5 more

Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from Mycobacterium tuberculosis

ACS Chemical Biology(2020)10.1021/acschembio.0c00184

N/A

0.510DataRank · unranked

29 citations

Huy Ngo, Selina Y. L. Holbrook, Keith Green, Melisa J. Willby, Shilah A. Bonnett +7 more

Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.0c01727

N/A

0.464DataRank · unranked

21 citations

Vinayak Singh, Alissa Myrick, Sandile B. Simelane, Dale Taylor, Christel Brunschwig +21 more

Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance

RSC Medicinal Chemistry(2021)10.1039/d1md00239b

N/A

0.442DataRank · unranked

18 citations

Keith Green, Atefeh Garzan, Nishad Thamban Chandrika, Melisa J. Willby, Allan H. Pang +8 more

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.974101

N/A

0.442DataRank · unranked

18 citations

Aditi Deshpande, Tanya Parish, Amala Bhagwat

Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event

Tuberculosis(2022)10.1016/j.tube.2022.102272

N/A

0.165DataRank · unranked

2 citations

Sasha E. Larsen, Matthew B. McNeil, Valerie A. Reese, Tiffany Pecor, Suhavi Kaur +4 more

Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.26.661674

N/A

0.104DataRank · unranked

1 citations

Christopher L. Harding, Diana Quach, Joseph Sugie, Joe Pogliano, Tanya Parish +1 more

Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis

Microbiology Spectrum(2023)10.1128/spectrum.04974-22

N/A

0DataRank · unranked

8 citations

Jo-Ann Jee, Somsundaram Chettiar, Yulia Ovechkina, Aaron Korkegian, Eric Greve +3 more

Benzene Amide Ether Scaffold is Active against Non-replicating and Intracellular Mycobacterium tuberculosis

ACS Infectious Diseases(2023)10.1021/acsinfecdis.3c00275

N/A

0DataRank · unranked

6 citations

Sultan Chowdhury, James Gomez, Deborah T. Hung, Tanya Parish, Sara Ahmed

SAR study of piperidine derivatives as inhibitors of 1,4-dihydroxy-2-naphthoate isoprenyltransferase (MenA) from Mycobacterium tuberculosis

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115125

N/A

0DataRank · unranked

7 citations

Pooja Hegde, Venugopal Pujari, Marzena Brinkmann, David Z. Wilkins, Tanya Parish +3 more

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor

Microbiology(2023)10.1099/mic.0.001345

N/A

0DataRank · unranked

1 citations

Aditi Deshpande, Amala Bhagwat, Tanya Parish, Bryan J. Berube

MSMEG_0918 is not Essential for the Growth of Mycobacterium smegmatis

PubMed(2023)10.17912/micropub.biology.000891

N/A

0DataRank · unranked

0 citations

Amala Bhagwat, Tanya Parish, Eldana Bedru

8-Hydroxyquinoline Series Exerts Bactericidal Activity against Mycobacterium tuberculosis Via Copper-Mediated Toxicity

ACS Infectious Diseases(2024)10.1021/acsinfecdis.4c00582

N/A

0DataRank · unranked

18 citations

Arielle Butts, Eric Greve, Yan Cheung, Eduard Melief, James Gomez +3 more

Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques

npj Antimicrobials and Resistance(2024)10.1038/s44259-024-00066-z

N/A

0DataRank · unranked

5 citations

Bryan J. Berube, Brendan K. Podell, Matthew H. Harband, Hadley E. Gary, Martin Perez-Jaimes +12 more

Common Biological Properties of Mycobacterium tuberculosis MmpL3 Inhibitors

ACS Infectious Diseases(2025)10.1021/acsinfecdis.5c00394

N/A

0DataRank · unranked

6 citations

R. H. Allen, Helena I. Boshoff, Laura A. T. Cleghorn, Curtis A. Engelhart, Dirk Schnappinger +2 more

Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.00980-25

N/A

0DataRank · unranked

1 citations

Christopher L. Harding, Diana Quach, Joseph Sugie, Joe Pogliano, Tanya Parish +1 more

The Tuberculosis Drug Accelerator at year 10: what have we learned?

Nature Medicine(2021)10.1038/s41591-021-01442-2

N/A

0DataRank · unranked

62 citations

David Barros-Aguirre, Clifton E. Barry, Robert H. Bates, Steven J. Berthel, Helena I. Boshoff +32 more

Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.12.091033

N/A

0DataRank · unranked

0 citations

Tanya Parish, Mai B. Thayer

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth

ACS Omega(2021)10.1021/acsomega.0c05589

N/A

0DataRank · unranked

33 citations

Margaret Huggett, Penelope A. Turner, Malcolm Taylor, Laura A. T. Cleghorn, Julie V. Early +32 more

Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis

PLoS ONE(2021)10.1371/journal.pone.0239353

N/A

0DataRank · unranked

2 citations

Tanya Parish, Mai B. Thayer

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions

ACS Infectious Diseases(2022)10.1021/acsinfecdis.1c00570

N/A

0DataRank · unranked

25 citations

Jun Zhang, Landys Lopez Quezada, Julia Roberts, Yan Ling, Madeleine Wood +39 more

Chemical exploration of a highly selective scaffold with activity against intracellular Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.18.481120

N/A

0DataRank · unranked

0 citations

Sara Ahmed, Alyssa J. Manning, Divya Awasthi, Yulia Ovechkina, Sultan Chowdhury +3 more